Adding an investor to a Cyprus company: decide more than the percentage

Identify who receives the investment money

Distinguish company funding from a purchase of a founder’s existing holding. A combined deal should state both components. This affects the commercial expectations about working capital and the documents needed; the headline investment amount should not conceal money paid outside the business.

Ask the parties to describe the transaction as a money-flow diagram. Identify the investor, company, any selling holders and the amount payable to each. If the headline commitment includes future tranches, state the conditions and dates proposed for them. Founders should distinguish money available for operations from money paid to an existing owner. The legal documents need to reflect the agreed route, while the accountant assesses the resulting financial treatment. A funding announcement should not present the entire headline figure as immediate working capital when the commercial terms say something different.

Official background: Registrar: updating share capital and shareholders.

Make the valuation assumptions visible

Record the proposed investment amount, valuation basis and ownership calculation. Explain outstanding options, promised shares or other instruments that could affect the model. The lawyer does not replace valuation advice, but needs the agreed assumptions to draft a coherent transaction.

Prepare the percentage model using an agreed valuation basis and list every assumption that affects it. Include existing share classes and any commitments that the parties say should enter the calculation. If a term sheet uses phrases such as pre-money or fully diluted, ask the participants to explain the calculation they intend rather than relying on a label. Valuation is a commercial and financial question requiring appropriate advice; the lawyer needs a clear agreed model to identify the transaction documents and detect an inconsistency with the promised ownership outcome.

Review the existing founders’ arrangements

Locate the articles, shareholder agreement and prior commitments. Identify approval or participation questions before promising terms to the investor. A new investment should be read against the existing deal between founders rather than pasted on top of inconsistent documents.

Review the founders’ existing bargain before negotiating a replacement. Identify decision rules, transfer arrangements, contributions and any unresolved commitment made during formation. An investor admission can expose a historic discrepancy, such as one founder promising shares to an early contributor without updating the records. Bring that issue into the brief rather than assuming the new investor agreement cures it automatically. A records review may be the appropriate first stage. Transaction drafting and implementation should be quoted separately where the work extends beyond the company-compliance service’s review scope.

Separate board representation from ownership

Describe the proposed director appointment and decision process. A board seat, observer role and information right are different commercial arrangements. Consider how meetings, papers and conflicts will work in practice, especially where an investor supports competing businesses or operates abroad.

For board involvement, describe the function the investor expects to perform. Will they participate in decisions, receive papers as an observer or obtain periodic reports without attending meetings? Explain confidentiality concerns and any relationship with competing businesses. A director nomination also creates questions about the appointee’s own role and information access. The company should not grant operational permissions simply because it accepted a commercial request for visibility. A clear governance brief helps the professional align the participation arrangement with the company documents and the practical meeting process.

Define reserved decisions narrowly enough to use

List the matters on which investor consent is proposed and distinguish strategic control from ordinary operations. An overbroad veto can make routine decisions difficult. Test the threshold and escalation process using the company’s actual budgets and expected transactions.

Test each proposed reserved matter against real examples. A threshold for borrowing should be compared with ordinary working-capital needs; a restriction on spending should be tested against the approved budget; a consent right over contracts should distinguish material commitments from routine renewals. Decide how requests are delivered and what happens when an investor does not respond. The legal assessment must address the actual wording, but the business should first explain which decisions it wants protected. A broad veto negotiated without operational examples can become an obstacle to ordinary management.

Plan information rights around useful reporting

Agree the information the investor needs, timing and confidential handling. Consider whether the business can produce the promised reports reliably. Unlimited informal access can burden staff or expose unnecessary information; a clear reporting process supports both governance and efficient operations.

Design the reporting schedule from the records the company can reliably maintain. Identify financial reports, key metrics and significant-event notices separately. Ask who prepares them, who verifies them and how confidential information is handled. If the business cannot produce a promised report without substantial new work, disclose that before signing. Investor visibility can be valuable without giving unrestricted access to every employee or customer record. The proposed reporting obligations should fit the company’s systems and any relevant privacy or confidentiality assessment, rather than depend on repeated informal document requests.

Discuss future funding before it becomes urgent

Explain expected funding needs and how further investment will be considered. Existing holders may have different willingness or capacity to contribute. Put the commercial positions into the brief without treating a broad promise to support the business as a binding funding mechanism.

Discuss a credible funding scenario before cash becomes scarce. Who expects to contribute, who can decline and how would a new outside investment be considered? Record the parties’ commercial positions and ask the lawyer to assess the appropriate structure. Avoid vague promises that each holder will support the company whenever needed. If future terms depend on valuation or another event, identify how that decision will be made. Founders should understand the potential effect on their holdings and decision-making position before accepting a plan that assumes every participant has the same future resources.

Align exit expectations and transfer arrangements

Describe what each party expects if a founder leaves, the investor sells or a buyer offers to acquire the company. Valuation, consent and sale cooperation questions should fit together. A funding agreement is more useful when it anticipates disagreement rather than only the initial subscription.

Use three separate exit scenarios: an individual founder leaves, the investor wants to sell, and a buyer offers to acquire the business. Compare the proposed transfer restrictions, consent process and sale cooperation arrangements in each. Ask how price or valuation disagreements would be addressed under the intended documents. A mechanism suitable for an investment exit might be inappropriate for a founder departure linked to employment. State the actual concern and obtain advice on the coherent set of terms, rather than adding several fashionable clauses whose interactions nobody has examined.

Build a completion plan with real dependencies

List due diligence, approvals, document execution, funding and record updates as distinct steps. Identify who verifies each condition. The commercial desire to announce a round should not convert an unresolved dependency into an assumed completed event.

Create a completion tracker that identifies the owner of each condition and the evidence showing it has been satisfied. The tracker might include agreed document review, approvals, signatures, funding and records coordination. Put an unresolved condition in the outstanding column even if everyone expects it to be straightforward. Keep announcements and operational commitments proportionate to the real state of the transaction. Authority processing or another provider’s checks should not be treated as part of the lawyer’s preparation estimate. The accepted scope should distinguish the work delivered from external dependencies.

Choose staged advice with a clear client

Identify whose interests the lawyer represents and separate other parties’ advice where needed. A term-sheet review, full documentation and company administration can be priced as distinct stages. The accepted scope should match the actual complexity and unresolved decisions rather than a generic investor package.

Identify whose interests each professional serves and which stage has been accepted. A founder term-sheet review can be useful before the company instructs full documentation; the investor may commission its own review. State whether negotiations, amended articles, share implementation and related record work are included or separately priced. A transparent fixed fee should identify the parties, documents and review rounds rather than promise an entire funding round under an ambiguous package. If the deal changes materially, agree a revised scope before the professional begins the additional work.

Questions worth asking